99429-68-2

Basic information

• Product Name: Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester
• Synonyms: Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester;Ethyl 4-hydroxy-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylate
• CAS NO: 99429-68-2
• Molecular Formula: C₁₀H₉NO₄S
• Molecular Weight: 239.24776
• Mol File: 99429-68-2.mol

Chemical Properties

• Boiling Point: 475.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.507±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 4.50±1.00(Predicted)
• CAS DataBase Reference: Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester(99429-68-2)
• EPA Substance Registry System: Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester(99429-68-2)

Safety Data

• Hazardous Substances Data: 99429-68-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Thieno[2,3-b]pyridine-5-carboxylic acid, 6,7-dihydro-4-hydroxy-6-oxo-, ethyl ester is used as a therapeutic agent for its anti-inflammatory, analgesic, and anti-cancer activities. Its ethyl ester form enhances its solubility and ease of administration, potentially improving its bioavailability and effectiveness in various therapeutic applications.
Further research is required to fully understand and harness the potential benefits of this compound, as its complex molecular structure and diverse applications necessitate a deeper understanding of its mechanisms of action and safety profile.

Upstream product

• 99429-66-0 2-ethoxycarbonyl-N-(3-ethoxycarbonyl-2-thienyl)acetamide 
• 1158651-78-5 methyl 2-{[3-(ethyloxy)-3-oxopropanoyl]amino}-3-thiophenecarboxylate 

Downstream Products

• 99429-78-4 4-hydroxythieno<2,3-b>pyridin-6(7H)-one 
• 272-23-1 thieno[2,3-b]pyridine 
• 62226-18-0 6-chlorothieno[2,3-b]pyridine 
• 99429-81-9 4-chlorothieno<2,3-b>pyridin-6(7H)-one 
• 99429-80-8 4,6-dichlorothieno<2,3-b>pyridine 
• 99429-84-2 6-chloro-4-methoxythieno<2,3-b>pyridine 
• 99429-87-5 4,6-dimethoxythieno<2,3-b>pyridine 
• 104515-21-1 4,6-dichloro-2-methylthieno<2,3-b>pyridine 
• 104515-22-2 2-bromo-4,6-dichlorothieno<2,3-b>pyridine 

Relevant articles and documents

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I ) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme

THIENOPYRIDINONE DERIVATIVES AS MACROPHAGE MIGRATION INHIBITORY FACTOR INHIBITORS

Inhibitors of macrophage migration inhibitory factor having a thienopyridinone backbone are provided which have utility in the treatment of a variety of disorders, including the treatment of pathological conditions associated with macrophage migration inhibitory factor activity. The inhibitors of macrophage migration inhibitory factor have the following structures formula (I), (II), (III) including forms such as stereoisomers, free forms, pharmaceutically acceptable salts or esters thereof, solvates, or combinations of such forms, wherein n, R1, R2, R3, X, and Y are as defined herein. Compositions comprising an inhibitor of macrophage migration inhibitory factor in combination with a pharmaceutically acceptable carrier are also provided, as well as methods for use of the same.